Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma.
Authors:
- J L BrowningJBJ L Browning
- C F WareCWC F Ware
Open Access
- 1 February 1992
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 267 (4) , 2542-2547
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lymphotoxin produced by human B- and T-cell lines appears in two distinct formsMolecular Immunology, 1991
- Expression of Membrane‐associated Lymphotoxin/Tumor Necrosis Factor‐β on Human Lymphokine‐activated Killer CellsJapanese Journal of Cancer Research, 1991
- A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contactCell, 1990
- Molecular cloning and expression of a receptor for human tumor necrosis factorCell, 1990
- Molecular cloning and expression of the human 55 kd tumor necrosis factor receptorCell, 1990
- Regulation of Protein Export From the Endoplasmic ReticulumAnnual Review of Cell Biology, 1988
- Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-αNature, 1987
- Molecular Cloning of a Complementary DNA Encoding Human Macrophage-Specific Colony-Stimulating Factor (CSF-1)Science, 1985
- Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityNature, 1984
- Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursorNature, 1983